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Abstract
A number of OECD countries have introduced waiting time prioritisation policies which give explicit priority
to severely ill patients with high marginal disutility of waiting. There is however little empirical evidence
on how patients are actually prioritised. We exploit a unique opportunity to investigate this issue using a
large national dataset with accurate measures of severity on over 200,000 patients. We link data from a
national patient-reported outcome measures survey to administrative data on all patients waiting for a
publicly funded hip and knee replacement in England during the years 2009-12. We find that patients
suffering the most severe pain and immobility have shorter waits than those suffering the least, by about
29% for hip replacement and 9% for knee replacement, and that the association is approximately linear.
These differentials are more closely associated with pain than immobility, and are larger in hospitals with
longer average waiting times.
Keywords: Waiting times, severity, prioritisation, patient-reported outcome measures
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1. Introduction
Waiting times are a major health policy concern in several OECD countries (Siciliani et al. 2013). Patients
seeking publicly funded care often have to wait weeks or months for many common elective procedures,
such as cataract surgery and hip and knee replacement. For example, in 2012 mean waiting times
for hip replacement were above 80 days in several OECD countries, with considerable variations, e.g.
above 150 days in Spain and about 50 days in the Netherlands (Siciliani et al. 2014). Waiting times
may generate discontent amongst patients as benefits from treatment get postponed and suffering and
uncertainty are prolonged (Lindsay and Feigenbaum 1984).
In the presence of constraints on capacity combined with public health insurance and limited or zero
co-payments, demand for treatment is likely to exceed supply, so that not all patients can be treated
immediately. Patients are therefore added to a waiting list and have to wait for public treatment unless
they are willing to pay for private care. Waiting times can be thought of as a non-monetary price which
brings together the demand for and the supply of treatments in a public healthcare system (Martin and
Smith 1999; Martin and Smith 2003; Iversen and Siciliani 2011).
A number of countries have experimented with policies to reduce waiting times, either by increasing the
capacity of the healthcare system, e.g. by allowing privately operated providers to treat publicly-funded
patients (Naylor and Gregory 2009), incentivising healthcare providers through maximum waiting time
targets or guarantees (Propper et al. 2008a), or by limiting demand through more stringent admission
policies. These policies have shown varying degree of success (Siciliani and Hurst 2005; Siciliani et al.
2013).
Waiting time prioritisation policies are intended to improve the management of the waiting list - rather
than affect demand or supply directly - and are common across OECD countries (Siciliani et al. 2013).
The key idea is simple. Given that waiting lists are unavoidable, they should be prioritised efficiently so
as to reduce suffering among more severely ill patients with higher marginal disutility of waiting. From
a theoretical perspective, it has been shown that such policies are welfare improving even in settings
where severity is only partially observable, since prioritisation reduces the overall deadweight loss from
waiting (Gravelle and Siciliani 2008; Gravelle and Siciliani 2009).1
Countries tend to differ in the way prioritisation operates. Some countries have developed formal
prioritisation tools based on detailed scores following a specialist visit (e.g. in Canada and New Zealand
for selected procedures) while others rely on relatively informal and generic tools (such as Australia and
Italy, which recommend different maximum waiting times based on three or four groups of patients). For
example, as part of the Western Canada Waiting List project, scoring tools have been developed that
integrate objective and subjective clinical and social measures to calculate an overall priority score. For
hip and knee replacement surgery this priority score is determined based on patients’ pain on motion
(e.g. bending, up to 13 points), pain at rest (e.g. sitting, up to 11 points), ability to walk without pain (up
to 7 points), other functional limitations (e.g. putting shoes on, managing stairs, up to 19 points), among
other factors. Similar tools are used in New Zealand to prioritise patients for several procedures (e.g. for
coronary bypass, hip and knee joint replacements) and specialties (e.g. in general and vascular surgery,
orthopaedics, ophthalmology and plastic surgery).2 In Norway, a recent policy has introduced a maximum
1 See also Siciliani and Iversen (2012) for a simpler model.
2 As an example, patients affected by ‘Lens-induced glaucoma’ should be treated within four weeks (urgent, 71-90 points); patients
categorised as ‘Cataract extraction required in order to treat posterior segment disease’ within 12 weeks (semi-urgent, 51-70
points); all other cataracts: (1-50 points) according to visual acuity score (max 5 points), clinical modifiers (max 5 points), severity
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waiting time guarantee where patients are eligible to treatment within an individually determined waiting
time. National guidelines were developed to stipulate maximum medically acceptable waits for a range of
diagnoses (see Siciliani et al. (2013) for a detailed description of prioritization policies).3
The English NHS does not implement a formal prioritisation policy. Hospital trusts and consultants
are allowed to manage the waiting list as they see fit, which gives rise to local variation in admission
policies. In some instances waiting lists may be managed according to a first-come-first-serve rule,
whereas in other instances management may take into account severity. For example, Leeds Teaching
Hospitals NHS Trust sets out the requirement to treat patients ‘in order by clinical priority, and then in
strict chronological order ’ (Leeds Teaching Hospitals NHS Trust 2014, p.4).
Despite the substantial interest in waiting-time prioritisation by policy makers and healthcare managers,
there is very limited evidence within the empirical literature about the degree of waiting time prioritisation
for patients affected by a common condition. It is therefore not evident a) to what extent patients are
prioritised on the waiting list, b) how steep the severity gradient in waiting is, and c) whether waits reduce
linearly or non-linearly with severity. Without this information it is difficult for decision-makers to determine
whether more efforts should be devoted to further encourage prioritisation of patients on the waiting list.
We aim at filling this gap in knowledge.
The lack of empirical studies on this topic may be explained by the absence of accurate measures of
severity in large-scale administrative databases. These databases are typically limited to measures of
comorbidity burden, which are poor proxies for general health status.4 In this study, we take advantage
of a new dataset containing detailed measures of patient self-reported health status collected alongside
routine surgery as part of the national patient-reported outcome measures (PROM) programme. Since
April 2009, all patients undergoing four elective surgical procedures (unilateral hip replacement, unilateral
knee replacement, groin hernia repair and varicose vein surgery) in the English National Health Service
(NHS) have been invited to report their health status before and several months after surgery (Department
of Health 2008). The pre-operative health status of the patient is measured through condition-specific
instruments (such as the Oxford Hip Score) and the generic EuroQol-5D instrument.
We focus on hip and knee replacement, which are common elective procedures and are the focus of
waiting time prioritisation policies in a number of OECD countries (e.g. Canada, New Zealand). We
test the extent to which more severely ill patients (as measured by the Oxford Hip and Knee Scores
(OHS/OKS) which captures patients’ joint-related pain and degree of mobility and autonomy) in the
English NHS wait less. We also explore the differential role of pain and mobility on waiting time by
splitting the Oxford scores into sub-components. We estimate Poisson models to allow for the discrete
measure of inpatient waits (in days) and the skewed distribution of waiting times. Critically, we control for
hospital fixed effects. Therefore, differences in waits across patients with different severity arise within
the hospital rather than across hospitals.
of visual impairment (max 10 points), ability to work, give care, live independently (max 5 points), other disability (max 5 points).
If patients score 21-50 they are considered ‘routine’ and should be treated within six months. Patients scoring less than 20 are
‘deferrable’ (Siciliani and Hurst 2005).
3 They were developed in co-operation between Directorate of Health and Regional Health Authorities and cover conditions within 32
main ‘medical chapters’. These describe a selection of medical conditions, a typical patient, and a recommendation on maximum
waiting time. It is physicians at hospitals who ultimately decide and the actual wait may therefore vary over recommendations, e.g.
due to patient’s age, treatment efficacy, or co-morbidities.
4 Gutacker et al. (2015a) report that patients’ self-reported pre-operative health status correlates poorly (ρ=-0.13) with the number of
Elixhauser comorbid conditions; a commonly used proxy for comorbidity burden.
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Our key result is that patients with higher severity tend to wait less but the effect appears to be modest.
Hip replacement patients in the top severity group wait approximately 9% (or 8 days) less than those with
average severity, and the total gap between patients in the most and least severe groups is 29% (or 25
days). There is heterogeneity across treatments: the gradient for patients in need of knee replacement
is substantially flatter, with no discernible prioritisation taking place between patients in above average
severity. Moreover, while both mobility and pain affect patients’ wait for hip replacement, only pain matters
for knee replacement.
When we split the sample between hospitals with high (above median) and low (below median) waits, we
find that the gradient between severity and waiting is more pronounced in hospitals with longer waits.
This suggests that doctors enhance prioritisation when waits increase in the attempt to reduce the overall
disutility from waiting. However, overall we find that prioritisation is currently limited in scope and therefore
we suggest that governments could do more to further encourage waiting time prioritisation.
1.1. Related literature
The study contributes to the existing literature on the role of waiting times in the health sector. A key
focus in this literature has been the estimation of demand and supply elasticities to waiting times. These
studies typically find that demand is inelastic to waiting times (with an elasticity of about -0.1) while
supply elasticity estimates vary depending on study design (Martin and Smith 1999; Martin and Smith
2003; Martin et al. 2007); see also Iversen and Siciliani (2011) for a review. Some studies focus on
specific policy interventions such as the introduction of maximum waiting-time guarantees combined with
penalties for non-compliance (e.g. Propper et al. 2008a; Dimakou et al. 2009) or the effect of competition
(Siciliani and Martin 2007; Propper et al. 2008b). Other studies focus on waiting-time inequalities by
socioeconomic status. Cooper et al. (2009) find that people living in more affluent areas waited less
than those in more deprived areas for cataract, hip and knee replacement surgery performed in the
English NHS (see also Laudicella et al. (2012), who focus on variations in waiting times within hospitals).
Similarly, Monstad et al. (2014) find that in Norway richer men and more educated women tend to
wait less for hip replacement; see also Kaarboe and Carlsen (2014). Similar evidence for Australia is
provided by Sharma et al. (2013) and Johar et al. (2013). There are also a number of empirical studies
that estimate the effect of longer waiting time on pre- and post-operative patient health. Hoogeboom
et al. (2009) provide a systematic review of the medical literature and find that longer waiting time is not
associated with deteriorations in health status while waiting up to six months. Using observational data
from the national PROM programme in England, Nikolova et al. (forthcoming) estimate that patients’
post-operative health status deteriorates by 0.1% of the outcome measure range per additional week of
wait.
Some recent studies from Norway focus on prioritisation. Askildsen et al. (2011) compare recommended
maximum waiting times by medical guidelines with actual waiting times. These guidelines recommend a
differential waiting time across different conditions rather than within a given condition (the focus being
therefore quite different from prioritisation within a condition as we pursue in this study). They find that
patients with the most severe conditions receive lower priority than recommended. The related study
by Januleviciute et al. (2013) also suggests that the introduction of such guidelines had no effect on
improving waiting time prioritisation across four major severity groups; see also Askildsen et al. (2010).
4 CHE Research Paper 114
2. Methods
We estimate fixed effects Poisson regression models to relate the number of days on the waiting list wij
for patient i = 1, . . . , nj in hospital j = 1, . . . , J to observed patient characteristics and the provider of
care (Cameron and Trivedi 1998).5 The model is specified as
wij = exp(β
′
1
sij + β
′
2
xij + hj) (1)
Coefficient estimates are semi-elasticities, representing the proportionate change in the dependent
variable resulting from a one unit change in the independent variable. We also report average partial
effects (APEs) on the untransformed scale.6 We obtained cluster-robust Huber-White standard errors to
account for potential over-dispersion (Cameron and Trivedi 1998).
The variable sij is our key variable of interest. It measures severity in terms of patients’ pain at rest or in
movement, and their ability to move about. This information is available from a national census of all
patients undergoing elective hip or knee replacement (more details are provided in the data section). The
vector β1 thus provides an estimate of the degree of waiting-time prioritisation on the list according to
severity as measured by pain and immobility. We allow for the relationship between severity and waiting
time to be non-linear by splitting severity into twelve bands, thus allowing for a potentially non-linear
‘severity gradient’ in waiting time.
There may be a number of other patient characteristics that are used for prioritisation and are correlated
with unobserved components of severity. We explore the robustness of the estimated severity gradient
in β1 to the inclusion of these characteristics. The vector xij includes the patient’s age (coded as 0-44,
45-54, 55-64, 65-74, 75-84 and 85+), sex and age-sex interactions as well as the number of emergency
admissions to hospital during the past 365 days, indicators for Elixhauser co-morbid conditions and
approximate socio-economic status (in quintile groups). A priori, age should affect only the eligibility
criteria for a hip (or knee) replacement within the NHS, not whether they are prioritised on the list.
However, age may be correlated with other factors of severity not already accounted for through patients’
self-reported health. Similarly, patients may be prioritised according to their co-morbidity burden and
general health status as approximated by past emergency admissions.
All models include hospital fixed effects hj to control for differences in waiting times across hospitals
which may arise from unobserved supply factors (e.g. availability of beds, nurses, doctors, infrastructure,
management and organization, and quality) and unobserved regional demand factors such as overall
health of the population. Hence, the coefficients on severity and other control variables are estimated
from within-provider variation only.
All analyses were conducted in Stata version 13.
5 The use of Poisson regression is preferable over (log-transformed) linear regression because it accounts for the skewed distribution
of waiting time and does not suffer from re-transformation bias (Manning 1998; Gould 2011).
6 The non-linear nature of the model requires evaluating APEs at the observed level of all covariates, including the overall intercept.
The fixed effect (FE) Poisson estimator in Stata 13 does not include an overall intercept in the model. Instead it specifies the
hospital FEs as the sum of the intercept plus the hospital-specific deviations from it. All FEs are conditioned out of the likelihood
prior to estimation. In order to recover the overall intercept, we follow Cameron and Trivedi (1998, p.281) and first calculate the
hospital FEs as
ĥj =
∑
i wij∑
i exp(β̂
′
1
sij + β̂
′
2
xij
and then take the average across all j, i.e.
∑
j ĥj . We then use this overall intercept in the calculation of the APEs.
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3. Data
We use patient-level data from Hospital Episode Statistics (HES) for all elective admissions for patients
aged 18 or over who underwent NHS-funded primary (i.e. non-revision) hip or knee replacement surgery
between April 2009 and March 2012 in NHS or private providers.7 HES contains rich information on
patients’ demographic and medical characteristics, small area of residence and on the hospital stay itself.
Privately-funded patients treated in the private sector are not included in HES and are excluded from our
analysis.8
We extract data on a number of patient characteristics from HES, including patients’ age, gender, the
number of emergency admissions in the year prior to their joint replacement surgery, as well as the
number of Elixhauser comorbid conditions recorded in all admissions in the previous year or the current
admission (Elixhauser et al. 1998; Gutacker et al. 2015b). We measure waiting time for each patient
as the time (in days) between the specialist’s decision to add the patient to the waiting list and their
admission. We use the 2010 Index of Deprivation (McLennan et al. 2011) to attribute to each patient the
proportion of residents claiming means-tested social security benefits in their Lower Super Output Area
(LSOA), which we interpret as a proxy of income deprivation.9
We link these data to information obtained as part of the national PROM programme (Department
of Health 2008). Since April 2009, all NHS-funded hip and knee replacement patients are invited to
report their health status and health related quality of life before and six months after surgery using a
paper-based questionnaire. The pre-operative questionnaire is administered by the hospital providing
the surgery, either on admission or during the last outpatient appointment preceding admission. The
paper questionnaires are then collated and sent to a central agency to be scanned and linked to the
inpatient records using a linkage algorithm developed by the Health & Social Care Information Centre.
The post-operative questionnaire is posted to patients by the central agency six months post surgery.
Participation in the PROM survey is compulsory for providers but optional for patients. Complete pre-
and post-operative questionnaires can be linked to HES records for about 60% of patients.10
Each PROM questionnaire includes a condition-specific and a generic instrument. The Oxford Hip or
Knee Scores (OHS/OKS) are condition-specific instruments with 12 questions on joint-related functioning
and pain (Dawson et al. 1996; Dawson et al. 1998). Each item is scored on a five-point scale, ranging
from four (no problems) to zero (severe problems). The overall score ranges from zero (worst) to 48 (best)
and is calculated by simple summation across items. For our main analysis we split this score into twelve
equally sized groups of four points each (coded as 0-4, 5-8, 9-12, 13-16, 17-20, 21-24, 25-28, 29-32,
33-36, 37-40, 41-44, 45-48). In further analysis we also use two sub-scores based on items relating to
mobility and pain (see Appendix for how items are matched to sub-scores); again coded as groups of
four points. The PROM questionnaire also includes the EQ-5D, a generic measure of HRQoL that can
be applied to different health conditions (Brooks 1996). We focus on the Oxford scores throughout this
paper because i) we expect them to be more sensitive to differences in severity as considered by the
consultant than the EQ-5D, ii) we do not wish to make comparisons across conditions, and iii) their focus
on pain and mobility mirrors the criteria used for prioritisation of hip replacement patients in the Canadian
7 See Department of Health (2008) for procedure codes. Patients having revision surgery are likely to differ from those receiving
primary surgery and are therefore excluded from our study.
8 Around 11% of the English population have supplementary private insurance and 16% of hip replacement surgeries are funded
privately (Commission on the Future of Health and Social Care in England 2014).
9 LSOAs have an average population of 1,500 inhabitants and are intended to be homogeneous with respect to housing tenure and
accommodation type.
10We provide characteristics of responders and non-responders in Table 2 in the results section.
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context (see Introduction). The correlation between the condition-specific and generic measures is high,
with ρ=0.74 for OHS and the EQ-5D utility score and ρ=0.70 for OKS and EQ-5D utility score.
No ethical approval was required for secondary data analysis.
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4. Results
4.1. Descriptive statistics
Over the three-year period considered there have been about 104,000 publicly funded hip replacement
procedures and about 111,000 knee replacement procedures for which pre-operative PROM data are
available. Descriptive statistics are provided in Table 1.
Table 1: Descriptive Statistics
Hip replacement
(N=103,518)
Knee replacement
(N=110,844)
Description Mean SD Mean SD
Waiting time (in days) 83.1 49.6 87.1 52.6
Pre-operative Oxford Score 17.6 8.3 18.4 7.8
Age 67.6 11.2 69.2 9.3
Gender (0=female, 1=male) 0.41 0.5 0.43 0.5
Percentage of individuals in households receiving low-income benefits 0.12 0.1 0.13 0.1
Number of emergency admissions in last 365 days 0.11 0.5 0.10 0.5
Number of Elixhauser comorbidities: 0 0.35 0.5 0.28 0.4
Number of Elixhauser comorbidities: 1 0.29 0.5 0.28 0.4
Number of Elixhauser comorbidities: 2 0.18 0.4 0.21 0.4
Number of Elixhauser comorbidities: 3-4 0.12 0.3 0.15 0.4
Number of Elixhauser comorbidities: 5+ 0.06 0.2 0.08 0.3
Financial year 2009/10 0.28 0.4 0.29 0.5
Financial year 2010/11 0.35 0.5 0.34 0.5
Financial year 2011/12 0.37 0.5 0.37 0.5
For hip replacement patients, the average observed waiting time (our dependent variable) is 83 days.
Patients are on average 68 years old and nearly 60% of patients are female. The average pre-operative
OHS is 17.6 points (on a range from 0 to 48). Patients had an average of 0.1 emergency admissions in
the year proceeding hospital admission for an elective hip replacement. Only 65% of patients had at
least one comorbid condition with only 6% reporting more than five. The average waiting time for knee
replacement surgery is slightly higher than for hip replacement surgery (87 vs 83 days). The other patient
characteristics are comparable to those of hip replacement patients and are not repeated here (but see
Table 1 for details). The distributions of pre-operative OHS and OKS are shown in Figures 1a and 1b.
Not all patients respond to the PROM survey. Table 2 compares the characteristics of responders
and non-responders as derived from HES. The gap in average waiting time between responders and
non-responders is one day for hip replacement patients and two days for knee replacement patients.
Given that the average waiting time is above 80 days, these differences are negligible. Similarly, while
non-responders tend to be slightly older, have a higher comorbidity burden and have been admitted more
often to hospital as an emergency in the preceding year, these differences are small in size and unlikely
to induce bias.
4.2. Estimates of the severity gradient in waiting time
Table 3 and Table 4 provide our key results for patients in need of hip and knee replacement, respectively.
All specifications include hospital and year fixed effects (not reported). Differences in waiting times across
patients with different severity can be interpreted as within the hospital, rather than across hospitals. The
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Figure 1: Distribution of pre-operative Oxford Hip/Knee Scores
Table 2: Comparison of responders and non-responders
Hip replacement Knee replacement
Responders
(N=103,518)
Non-responders
(N=72,339)
Responders
(N=110,844)
Non-responders
(N=83,275)
Variable Mean SD Mean SD Mean SD Mean SD
Waiting time 83.11 49.6 84.19 54.7 87.14 52.6 89.13 57.8
Age 67.59 11.2 68.67 11.7 69.16 9.3 70.12 9.5
Gender (0=female, 1=male) 0.41 0.5 0.39 0.5 0.43 0.5 0.42 0.5
Percentage of individuals in households
receiving low-income benefits
0.12 0.1 0.13 0.1 0.13 0.1 0.14 0.1
Number of Elixhauser comorbidities 1.55 3.0 1.76 3.6 1.79 3.2 1.95 4.1
Number of emergency admissions in last
365 days
0.11 0.5 0.15 0.5 0.10 0.5 0.13 0.5
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Table 3: Regression results - hip replacement
Pre-operative health
only
Pre-operative health
and age/sex Full adjustment
Covariate Est SE Est SE Est SE
Pre-operative score: 5-8 0.050 0.011*** 0.047 0.011*** 0.047 0.011***
Pre-operative score: 9-12 0.068 0.010*** 0.065 0.010*** 0.065 0.010***
Pre-operative score: 13-16 0.084 0.011*** 0.080 0.011*** 0.081 0.011***
Pre-operative score: 17-20 0.095 0.012*** 0.092 0.011*** 0.095 0.011***
Pre-operative score: 21-24 0.112 0.012*** 0.109 0.012*** 0.111 0.012***
Pre-operative score: 25-28 0.139 0.012*** 0.136 0.012*** 0.139 0.012***
Pre-operative score: 29-32 0.161 0.013*** 0.161 0.013*** 0.165 0.013***
Pre-operative score: 33-36 0.170 0.015*** 0.168 0.014*** 0.172 0.015***
Pre-operative score: 37-40 0.192 0.017*** 0.191 0.017*** 0.197 0.017***
Pre-operative score: 41-44 0.213 0.033*** 0.212 0.033*** 0.217 0.033***
Pre-operative score: 45-48 0.273 0.084** 0.276 0.084** 0.285 0.084***
Age: 45-54 -0.032 0.016* -0.034 0.016*
Age: 55-64 -0.078 0.016*** -0.080 0.016***
Age: 65-74 -0.110 0.016*** -0.114 0.016***
Age: 75-84 -0.133 0.017*** -0.138 0.017***
Age: 85+ -0.137 0.019*** -0.141 0.019***
Male -0.045 0.019* -0.047 0.019*
Past emergency utilisation -0.017 0.006**
SES (2nd quintile) 0.000 0.005
SES (3rd quintile) 0.007 0.006
SES (4th quintile) 0.015 0.006*
SES (5th quintile - most deprived) 0.015 0.006*
N 103,518 103,518 103,518
*** p<0.001; ** p<0.01; * p<0.05
Notes: Estimates are semi-elasticities and relative to patient aged <44, female, and pre-operative Oxford score of 0-4. All
models include hospital and year fixed effects. Standard errors are robust to over-dispersion. Age-sex interactions not
reported (mostly statistically insignificant).
model in Column (1) only includes the Oxford Score. The model in Column (2) extends this to account
for patient’s age and gender, and the model in Column (3) contains a full set of control variables. The
severity gradient is formed by the coefficients on each of the Oxford Score groups. It is robust to the
inclusion of additional control variables. We therefore focus our discussion on the results in Column (3).
Table 3 suggests that hip replacement patients with lower severity, as measured by the Oxford Hip Score,
wait longer. The quantitative effect appears to be modest. Compared to patients in the top severity group
(0-4 points) patients of average severity (17-20 points) wait 9% (or about 8 days) longer. Patients with
least severity (with a score above 37 points) wait at least 20% (16 days) longer. The gap between most
and least severe patients is on average 25 days. Figure 2 plots the average partial effect of Oxford Hip
Scores on waiting times in terms of days waited. The severity gradient increases linearly across the
entire range, suggesting a simple prioritisation mechanism.
Several other patient characteristics are also predictive of waiting time. For a given level of severity, older
patients tend to wait less. Patients over 65 years old wait about 11-14% less than patients below 45
years (and about 8-10% less than patients aged 45-54). Male patients wait 5% less. The age gradient
is not statistically significantly different for men and women and it is therefore not reported. Patients
who had been admitted to hospital as an emergency within the last year wait less than those who had
not. Only a few Elixhauser comorbidities have a statistically significant effect on observed waiting time
(not reported). Finally, there remains a statistically significant but very small socio-economic gradient in
waiting time even after conditioning on pre-operative severity and other patient characteristics. Patients in
the most income-deprived fifth of neighbourhoods wait approximately 1.5% longer than those in the least
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Figure 2: Partial effect of severity on waiting time (in days)
deprived fifth of neighbourhoods. If some of these patient characteristics pick up unobserved severity
differences, our severity gradient should be considered a lower bound estimate of the true gradient.
Table 4 reports results for knee replacement. The results are analogous to those for hip replacement,
though the gradient associated with OKS is notably flatter at about half the slope. Patients below 25 OKS
points do not differ significantly in waiting times. Patients with scores in the range of 25 to 44 wait about
4-10% longer compared to patients with a score below 25. The overall effect of severity on waiting time
is small and different severity groups differ by no more than 10 days (see Figure 2). Again, prioritisation
appears to be almost linear, ignoring the top two groups which include very few observations and are
estimated with large confidence intervals. Patients older than 75 years wait about 7% less than younger
patients. There is no statistically significant difference across genders or socio-economic groups.
4.3. Different dimensions of severity: pain or mobility
We now explore whether prioritisation differs by pain and mobility. The results in Table 5 show that, for
hip replacement surgery, both pain and mobility matter but the effect of pain on prioritisation is larger.
For example, a patient who scores 13-16 points on the pain score (higher scores indicate lower pain) is
expected to wait 8% (7 days) longer than a patient with extreme pain, for a given level of mobility (see
also Figure 3). Conversely, a patient who scores 13-16 points on the mobility score is only expected to
wait 4% (3 days) longer than the most immobile patient.
The results are different for knee replacement. Here, it is mainly different degrees of pain that generate
differences in waiting times and account for most of the gradient. Variations in severity due to mobility
have generally no effect on prioritisation (Figure 3).
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Table 4: Regression results - knee replacement
Pre-operative health
only
Pre-operative health
and age/sex Full adjustment
Covariate Est SE Est SE Est SE
Pre-operative score: 5-8 -0.015 0.014 -0.015 0.014 -0.014 0.014
Pre-operative score: 9-12 -0.004 0.014 -0.002 0.014 -0.002 0.014
Pre-operative score: 13-16 -0.003 0.015 0.001 0.015 0.003 0.015
Pre-operative score: 17-20 -0.001 0.014 0.005 0.014 0.007 0.014
Pre-operative score: 21-24 0.011 0.015 0.019 0.015 0.022 0.015
Pre-operative score: 25-28 0.026 0.015 0.037 0.015* 0.040 0.016**
Pre-operative score: 29-32 0.045 0.015** 0.057 0.015*** 0.061 0.015***
Pre-operative score: 33-36 0.053 0.018** 0.068 0.019*** 0.072 0.019***
Pre-operative score: 37-40 0.081 0.023*** 0.098 0.023*** 0.101 0.023***
Pre-operative score: 41-44 0.072 0.033* 0.088 0.034** 0.091 0.034**
Pre-operative score: 45-48 0.073 0.069 0.089 0.070 0.088 0.070
Age: 45-54 0.003 0.028 -0.001 0.028
Age: 55-64 -0.004 0.028 -0.009 0.028
Age: 65-74 -0.048 0.028 -0.054 0.028
Age: 75-84 -0.068 0.029* -0.075 0.029**
Age: 85+ -0.065 0.029* -0.070 0.029*
Male -0.005 0.041 -0.004 0.041
Past emergency utilisation -0.013 0.004***
SES (2nd quintile) -0.001 0.005
SES (3rd quintile) -0.006 0.005
SES (4th quintile) -0.007 0.006
SES (5th quintile - most deprived) 0.000 0.006
N 110,844 110,844 110,844
*** p<0.001; ** p<0.01; * p<0.05
Notes: Estimates are semi-elasticities and relative to patient aged <44, female, and pre-operative Oxford score of 0-4. All
models include hospital and year fixed effects. Standard errors are robust to over-dispersion. Age-sex interactions not
reported (mostly statistically insignificant).
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Table 5: Effect of pain and mobility on waiting time
Pain Functioning
Covariate Est SE Est SE
Hip replacement (N=103,518)
Pre-operative score: 5-8 0.027 0.005*** 0.019 0.006**
Pre-operative score: 9-12 0.050 0.006*** 0.031 0.007***
Pre-operative score: 13-16 0.082 0.008*** 0.039 0.008***
Pre-operative score: 17-20 0.097 0.012*** 0.059 0.011***
Pre-operative score: 21-24 0.083 0.025*** 0.078 0.018***
Knee replacement (N=110,844)
Pre-operative score: 5-8 0.015 0.004*** -0.003 0.008
Pre-operative score: 9-12 0.037 0.007*** -0.011 0.009
Pre-operative score: 13-16 0.059 0.011*** 0.005 0.010
Pre-operative score: 17-20 0.119 0.029*** 0.014 0.011
Pre-operative score: 21-24 0.029 0.013*
Pre-operative score: 25-28 -0.003 0.029
*** p<0.001; ** p<0.01; * p<0.05
Notes: Estimates are semi-elasticities and relative to pre-operative score of 0-4. All
models include hospital and year fixed effects + a full set of control variables (see text).
Standard errors are robust to over-dispersion.
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Figure 3: Differential effect of pain and mobility on waiting time
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4.4. Hospitals with long and short waiting times
We also test whether prioritisation is more pronounced when waiting times are longer. To do so we split
the sample into two groups, hospitals with an average wait above the median and hospitals below the
median.11
Table 6 provides the results. We focus on our preferred specification, which includes all controls. It
shows that the prioritisation gradient is comparable among the two groups when differences in waits
are measured in percentage points (with possibly a stronger gradient in long-wait hospitals for low OHS
scores, i.e. high severity, and a weaker gradient for high scores). However, the underlying levels are
different.
Figure 4 plots the gradients in days. Excluding the two top groups (i.e. low-severity patients with
infrequent observations) less severe patients can wait up to 19 days longer than severe patients in
high-wait hospitals. Conversely, less severe patients in low-wait hospitals wait only up to 10 days longer.
Therefore waiting time prioritisation is more pronounced in absolute terms in hospitals with longer average
waiting times.
A similar picture arises when looking at knee replacement patients (Figure 5). Prioritisation is more
pronounced in long-wait hospitals. In short-wait hospitals there are very little discernible differences
between different severity groups. In high-wait hospitals, prioritisation tends to be linear and patients with
lower severity wait up to about 10 days longer.
Table 6: Difference in waiting time gradient between short and long wait hospitals
Hip replacement Knee replacement
Low waiting
time hospitals
High waiting
time hospitals
Low waiting
time hospitals
High waiting
time hospitals
Covariate Est SE Est SE Est SE Est SE
Pre-operative score: 5-8 0.042 0.025 0.048 0.012*** -0.043 0.030 -0.008 0.016
Pre-operative score: 9-12 0.056 0.021** 0.068 0.011*** -0.033 0.033 0.005 0.015
Pre-operative score: 13-16 0.073 0.021*** 0.083 0.012*** -0.051 0.032 0.016 0.017
Pre-operative score: 17-20 0.096 0.023*** 0.094 0.013*** -0.031 0.030 0.016 0.016
Pre-operative score: 21-24 0.127 0.024*** 0.107 0.013*** -0.013 0.030 0.030 0.017
Pre-operative score: 25-28 0.153 0.026*** 0.136 0.013*** 0.030 0.034 0.041 0.017*
Pre-operative score: 29-32 0.199 0.031*** 0.157 0.014*** 0.033 0.035 0.066 0.016***
Pre-operative score: 33-36 0.193 0.038*** 0.168 0.016*** 0.057 0.040 0.073 0.021***
Pre-operative score: 37-40 0.161 0.047*** 0.203 0.018*** 0.101 0.044* 0.099 0.027***
Pre-operative score: 41-44 0.314 0.126* 0.202 0.031*** 0.069 0.091 0.093 0.035**
Pre-operative score: 45-48 0.808 0.448 0.226 0.067*** -0.251 0.214 0.129 0.074
N 30,373 73,145 35,151 75,693
11The median hospital level waiting time is 78 days for hip replacement surgery and 80 days for knee replacement surgery.
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Figure 4: Partial effect of severity on waiting time in short and long wait hospitals - hip replacement
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Figure 5: Partial effect of severity on waiting time in short and long wait hospitals - knee replacement
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5. Discussion
Many OECD countries are either faced with cuts to their healthcare budgets or small nominal growth, in
part driven by efforts to reduce budget deficits in the aftermath of the global economic crisis. This is likely
to affect the supply of care, which can no longer keep up with the increasing demand for care due to an
aging population. As a result, many healthcare systems are seeing and will see increases in waiting time
for elective surgery.
Waiting time prioritisation policies are one way to optimise the management of the waiting list and thus
maximise patients’ welfare. A number of countries have adopted formal or informal processes by which
patients are prioritised according to their observed severity, i.e. the need for timely care. Yet, there is
little empirical evidence on the degree to which prioritisation policies are implemented or how steep the
severity gradient in waiting time is in practice.
Using data on waiting time and self-reported pre-operative health status for over 200,000 patients
undergoing elective hip and knee replacement in the English NHS, we demonstrate a statistically
significant, albeit modest severity gradient in waiting time. For every four points on the Oxford Hip Score
(ranging from 0 (worst) to 48 (best)) we see an increase in waiting time of approximately two days. This
applies across the entire range of severity. Conversely, waiting times increase by approximately 1-2 days
for every four points increase on the Oxford Knee Score for knee replacement patients with pre-operative
scores above 24. There is no discernible gradient among more severe patients. Prioritisation for hip and
knee replacement surgery is driven primarily by the amount of pain patients receive from their joint, with
less importance given to mobility.
The overall severity gradient in waiting time seems modest in absolute terms. This may be because the
English NHS has not adopted a formal model of prioritisation for hip and knee replacement surgery, i.e. it
implements a ‘first-come-first-serve’ model, or because average waiting times are now at a historic low
so that prioritisation is considered less important.
Prioritisation is enhanced when waits are longer. This is supported by our finding that hospitals with
above median waiting times tend to show stronger prioritisation in absolute terms than hospitals with
below median waiting times. As waiting times begin to gradually increase again in the English NHS, we
would expect to see more prioritisation taking place.
Several other patient characteristics are associated with differences in waiting time. For example we
observe an age gradient. This may be considered as pro-elderly evidence of inequality in access to
care. However, it may also be a selection issue in terms of which patients are able and willing to choose
privately funded treatment — for example, if elderly patients are wealthier than younger patients with
severe osteoarthritis. We also cannot rule out that our measure of severity is imperfect and that these
variables capture some unobserved component of severity. In this case, our estimate of the severity
gradient is a lower bound.
More generally, our study has a number of possible limitations. First, our pre-operative health status
measures are taken at the time of admission, not when the specialist makes the decision to add the
patient to the waiting list. This may potentially overestimate the severity of some patients if the patients’
health status deteriorates during long waits. However, a recent systematic review by Hoogeboom et al.
(2009) finds that the degree of deterioration in health during waiting times < 6 months is likely to be
minimal and we therefore do not expect this to be a serious concern for our study. Second, not all patients
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respond to the PROM questionnaire, which may give rise to possible selection bias. However, such bias
is likely to be small as we find only very small difference in the average waiting time for responders and
non-responders.
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6. Conclusions
Hip and knee replacement patients in the English NHS are being prioritised according to severity, even
though no formal national prioritisation policy is currently in place. However, the degree of prioritisation is
modest. The size of the gradient implies that those responsible for the waiting list either believe that the
marginal disutility of waiting for surgery does not vary substantially across patients, or that they find it
difficult (perhaps even unethical) to prioritise patients according to their pain and limitations to mobility.
There is a clear rationale for prioritising patients on the list: the overall pain and limitations to mobility can
be reduced by letting more severe patients wait less. Following initiatives in other OECD countries, the
English NHS and other healthcare systems faced with increasing excess demand for elective surgery
should put more emphasis in encouraging further prioritisation on the list and consider formal policies to
enforce this.
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Appendix
Table A1: Mapping of questions to sub scores - Oxford Hip Score
# Pain
1 How would you describe the pain you usually had from your hip?
2 Have you had any sudden, severe pain - ’shooting’, ’stabbing’ or ’spasms’ - from the affected
hip?
3 Have you been troubled by pain from your hip in bed at night?
4 For how long have you been able to walk before pain from your hip becomes severe? (With
or without a stick)
5 After a meal (sat at a table), how painful has it been for you to stand up from a chair because
of your hip?
6 How much has pain from your hip interfered with your usual work (including housework)?
Mobility
7 Have you had any trouble with washing and drying yourself (all over) because of your hip?
8 Have you had any trouble getting in and out of a car or using public transport because of
your hip?
9 Have you been able to put on a pair of socks, stockings or tights?
10 Could you do the household shopping on your own?
11 Have you been able to climb a flight of stairs?
12 Have you been limping when walking, because of your hip?
Table A2: Mapping of questions to sub scores - Oxford Knee Score
# Pain
1 How would you describe the pain you usually have from your knee?
2 Have you been troubled by pain from your knee in bed at night?
3 For how long have you been able to walk before pain from your knee becomes severe?
(With or without a stick)
4 After a meal (sat at a table), how painful has it been for you to stand up from a chair because
of your knee?
5 How much has pain from your knee interfered with your usual work (including housework)?
Mobility
6 Have you had any trouble with washing and drying yourself (all over) because of your knee?
7 Have you had any trouble getting in and out of a car or using public transport because of
your knee?
8 Have you been limping when walking, because of your knee?
9 Could you kneel down and get up again afterwards?
10 Have you felt that your knee might suddenly ’give way’ or let you down?
11 Could you do the household shopping on your own?
12 Could you walk down one flight of stairs?
